| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.2 |